The present invention relates to the use of geraniol or any of its saturated or unsaturated monoterpene derivatives as a bacterial efflux pump inhibitor, for reducing antibiotic or antiseptic resistance or restoring antibiotic or antiseptic sensitivity to an antibiotic or antiseptic-resistant bacterial strain.